| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/15/1992 | EP0466505A2 Artificial antibody |
| 01/15/1992 | EP0466204A1 Novel polypeptides, DNAs that code for the same, and method of preparing said polypeptides and DNAs |
| 01/15/1992 | EP0466199A1 Polypeptide fragments of factor VIIIc, corresponding probes and DNA sequences and DNA constructs |
| 01/15/1992 | EP0466037A2 Process for enhancing the resistance of aquatic animals to disease |
| 01/15/1992 | EP0465979A1 Anti HTLV-III (strain MN) monoclonal antibody |
| 01/15/1992 | EP0465895A1 WS7622A di- sulfate, process for preparation thereof and use thereof |
| 01/15/1992 | EP0465602A1 METHOD FOR DETECTION AND/OR IDENTIFICATION OF $i(LYSSAVIRUS) INFECTIONS, CLONING AND EXPRESSION OF GENES CODING FOR PEPTIDES AND/OR FRAGMENTS OF PEPTIDES OF MOKOLA $i(LYSSAVIRUS), VACCINE AGAINST THE MOKOLA VIRUS AND/OR THE FAMILY OF $i(LYSSAVIRUSES) AS WELL AS METHOD FOR OBTAINING SAID VACCINE VIA |
| 01/15/1992 | EP0465561A1 Avirulent microbes and uses therefor |
| 01/15/1992 | EP0465539A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 01/15/1992 | EP0465529A1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 01/15/1992 | EP0465517A1 Method of preparing a vaccine |
| 01/15/1992 | EP0465513A1 FORMULATIONS FOR STABILIZING OF IgM ANTIBODIES |
| 01/15/1992 | EP0465495A1 Ribozome inactivating proteins and derivatives thereof |
| 01/15/1992 | EP0230456B1 The protection of equines against streptococcus equi |
| 01/15/1992 | CN1057861A Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide |
| 01/15/1992 | CN1057785A Synthetic poly-ig receptor, receptor-antibody complexes, production and use thereof |
| 01/14/1992 | US5081226 Synthetic peptides sharing sequence homology with the HIV envelope protein |
| 01/14/1992 | US5081135 Bactericides |
| 01/14/1992 | US5081108 Method of showing progression of AIDS in an ARC patient by treating with Tyr-Gly compositions |
| 01/14/1992 | US5081034 Genetic engineering |
| 01/14/1992 | US5081029 Acitivation of T lymphocytes |
| 01/14/1992 | US5081028 Preparation of transformed hosts which express binding factor related polypeptides |
| 01/14/1992 | US5080896 Synthetic immunogen |
| 01/14/1992 | CA1294218C Method and agents for inhibiting protein aging |
| 01/13/1992 | WO1992001051A1 Immunogenic peptide sequence from echinococcus granulosus, dna sequence coding for said peptide sequence, and diagnostic and therapeutic uses thereof |
| 01/13/1992 | CA2087005A1 Immunogenic peptide sequence from echinococcus granulosus, dna sequence coding for said peptide sequence, and diagnostic and therapeutic uses thereof |
| 01/12/1992 | WO1992000755A1 Immune system stabilizers for prevention and therapy of disorders associated with immune system dysfunction |
| 01/12/1992 | CA2087018A1 Immune system stabilizers for prevention and therapy of disorders associated with immune system dysfunction |
| 01/12/1992 | CA2046543A1 Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
| 01/09/1992 | WO1992000330A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 01/09/1992 | WO1992000329A1 Surface complexed lymphotoxin |
| 01/09/1992 | WO1992000327A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a) |
| 01/09/1992 | WO1992000326A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(b) |
| 01/09/1992 | WO1992000323A2 HUMAN CYTOMEGALOVIRUS (HCMV) ANTIGEN pp150 |
| 01/09/1992 | WO1992000101A1 Improved adjuvants and vaccines |
| 01/09/1992 | WO1992000098A1 Methods of inducing immune response to aids virus |
| 01/09/1992 | WO1992000097A1 Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza |
| 01/09/1992 | WO1992000093A1 Transfer factor and methods of use |
| 01/09/1992 | WO1992000092A1 Ligand for cd28 receptor on b cells and methods |
| 01/09/1992 | WO1992000091A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 01/09/1992 | WO1992000055A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 01/09/1992 | WO1991007483A3 Mammalian pancreatic cholesterol esterase |
| 01/09/1992 | CA2086610A1 Transfer factor and methods of use |
| 01/09/1992 | CA2086091A1 Human macrophage inflammatory protein 2o |
| 01/09/1992 | CA2086088A1 Human macrophage inflammatory protein 2.beta. |
| 01/09/1992 | CA2084510A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 01/09/1992 | CA2084413A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 01/08/1992 | EP0465204A2 Vaccine against Lyme disease and a challenge model for evaluating vaccine efficacy |
| 01/08/1992 | EP0465081A1 Viral decoy vaccine |
| 01/08/1992 | EP0464533A1 Fusionproteins with parts of immunoglobulins, their production and use |
| 01/08/1992 | EP0464287A1 Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide |
| 01/08/1992 | EP0464147A1 Matrix metalloproteinase inhibitor peptides |
| 01/08/1992 | EP0464137A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives |
| 01/08/1992 | EP0464096A1 Method of preparing vaccines |
| 01/08/1992 | CN1057655A Ws7622a mono-or di-sulfate, process for preparation thereof and use thereof |
| 01/07/1992 | WO1992001001A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes |
| 01/07/1992 | US5079353 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 01/07/1992 | US5079344 Monoclonal antibodies, hybridomas or cells |
| 01/07/1992 | US5079342 Diagnosis of AIDS |
| 01/07/1992 | US5079262 Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid |
| 01/07/1992 | US5079165 Vaccines to prevent cholera and typhoid fever |
| 01/07/1992 | US5079156 Crosslinked Polyvinyl Acylate Polymers |
| 01/07/1992 | US5078985 Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction |
| 01/07/1992 | CA2086761A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes |
| 01/07/1992 | CA2046025A1 Vaccine against lyme disease and a challenge model for evaluating vaccine efficiency |
| 01/04/1992 | WO1992000763A1 Immunoreactive compound |
| 01/04/1992 | CA2086531A1 Immunoreactive compound |
| 01/03/1992 | WO1992000372A1 Recombinant pigeon pox virus vaccine |
| 01/03/1992 | CA2084064A1 Recombinant pigeon pox virus vaccine |
| 01/02/1992 | EP0463848A2 Non-A, non-B hepatitis virus particles |
| 01/02/1992 | EP0463157A1 Lfa-3 as a vaccine adjuvant |
| 01/02/1992 | EP0463080A1 Cd8-based pharmaceuticals |
| 01/02/1992 | EP0463073A1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA |
| 01/02/1992 | EP0463059A1 Allergenic proteins from ragweed and uses therefor |
| 01/02/1992 | EP0463053A1 Production and use of anthelmintic agents and protective immunogens |
| 01/02/1992 | EP0463037A1 Human macrophage migration inhibitory factor |
| 01/02/1992 | EP0354909B1 Variable crosslinked polymeric supports |
| 01/02/1992 | EP0196319B1 Retroviral polypeptides associated with human cellular transformation |
| 01/02/1992 | EP0179152B1 Diagnostic system for the detection of cytomegalovirus |
| 12/31/1991 | WO1992000328A1 Non-a non-b sequences |
| 12/31/1991 | US5077213 Recombinant vaccinia virus |
| 12/31/1991 | US5077195 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
| 12/31/1991 | US5077193 Diagnostic kits |
| 12/31/1991 | US5077044 Prevention bacillary dysentery |
| 12/31/1991 | CA2072092A1 Non-a non-b sequences |
| 12/30/1991 | WO1992000081A1 Vaccine compositions containing liposomes |
| 12/28/1991 | WO1992000099A1 Method of introducing a peptide into the cytosol |
| 12/28/1991 | CA2086342A1 Method of introducing a peptide into a cytosol |
| 12/27/1991 | EP0462627A1 Antigens and peptides of lav. |
| 12/27/1991 | EP0462551A1 HIV GP120 monoclonal antibodies |
| 12/27/1991 | EP0462534A2 Acellular anti-pertussis vaccines |
| 12/27/1991 | EP0462305A1 Aerosol containing cytokines and use thereof |
| 12/27/1991 | EP0462246A1 Oligomeric immunoglobulins |
| 12/27/1991 | EP0462229A1 Chemically modified cd4 peptide fragments having anti-retroviral properties |
| 12/27/1991 | EP0462215A1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 12/27/1991 | EP0462147A1 Monoclonal antibodies to synthetic pyrethroids and method for detecting the same |
| 12/27/1991 | EP0462111A1 Homing sequences and their uses |
| 12/26/1991 | WO1991019803A1 Self assembled, defective, nonself-propagating viral particles |
| 12/26/1991 | WO1991019785A1 THE RETROVIRUS SIVcpz-ant AND ITS USES |
| 12/26/1991 | WO1991019744A1 Hepatitis c virus antigen polypeptide, production thereof, and detection of antibody |